BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2008
View Archived Issues
Adjunctive topiramate decreases compulsions in obsessive-compulsive disorder
Read More
Levetiracetam shows promise in body dysmorphic disorder
Read More
Studies evaluate prevention of post-stroke depression, PTSD with escitalopram
Read More
Promising results with antisense oligonucleotide PRO-051 in Duchenne's muscular dystrophy
Read More
Positive data reported for Acambis' ACAM-FLU-A influenza vaccine
Read More
Positive results found in QuatRx's pivotal postmenopausal vaginal syndrome study
Read More
GSK and Theravance initiate phase IIb ICS and LABA studies for asthma
Read More
FDA accepts IND application for EntreMed's Aurora kinase/angiogenesis inhibitor
Read More
DOR BioPharma's oral BDP designated orphan drug in pediatric Crohn's disease
Read More
Novel mineralocorticoid receptor antagonists emerge from Bayer R&D
Read More
Recent Roche patent describes new cognition enhancers for Alzheimer's disease
Read More
Allergan patents novel antiglaucoma agents
Read More
New oncolytic drugs imparted in recent patents
Read More
Daiichi Sankyo and Lilly submit NDA to FDA for oral antiplatelet agent prasugrel
Read More
Genmab initiates HuMax-CD32b preclinical program for IgG1,k antibody
Read More
FDA grants orphan drug designation to Ovation's clobazam for Lennox-Gastaut syndrome
Read More
Kosan initiates TIME-1 phase III clinical trial of tanespimycin for multiple myeloma
Read More
EMEA agrees with Spectrum's clinical development plan for phase III trials of EOquin
Read More
Millennium presents an update on Velcade, MLN-0002, MLN-4924 and MLN-2238
Read More
Infinity and MedImmune initiate phase Ib clinical trial of IPI-504 with Taxotere
Read More
MethylGene files IND application with the FDA for c-MET inhibitor MGCD-265
Read More
Protox reports positive final results from phase I study of PRX-302 for BPH
Read More
